Lipeng Xu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 3

Top Topics

Breast Cancer Risk

Lipopolysaccharide Induced

Roux En Y Gastric Bypass

Signaling Pathway

Top Venues

Toxicology research

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Chu Zhang, Yupei Liao, Tangjia Li, Haijing Zhong, Luchen Shan, Pei Yu, Chenglai Xia, Lipeng Xu
Apigenin promotes apoptosis of 4T1 cells through PI3K/AKT/Nrf2 pathway and improves tumor immune microenvironment in vivo. Toxicology research 13 (1) (2024)
Chu Zhang, Yupei Liao, Tangjia Li, Haijing Zhong, Luchen Shan, Pei Yu, Chenglai Xia, Lipeng Xu
Apigenin promotes apoptosis of 4T1 cells through PI3K/AKT/Nrf2 pathway and improves tumor immune microenvironment in vivo. Toxicology research 13 (1) (2024)
Mei Jing, Yuqiang Wang, Lipeng Xu
Andrographolide Derivative AL-1 Ameliorates Dextran Sodium Sulfate-Induced Murine Colitis by Inhibiting NF-κB and MAPK Signaling Pathways. Oxidative medicine and cellular longevity 2019 (2019)